Lunai Bioworks to effect 10:1 reverse stock split

* Lunai Bioworks (NASDAQ:RENB [https://seekingalpha.com/symbol/RENB]) announced on Wednesday that the company's Board of Directors has approved a 10:1 reverse stock split of its issued and outstanding common stock, to be effective on September 30, 2025.
* The company's common stock will trade on Nasdaq under the symbol "LNAI" following the reverse stock split, with a new CUSIP number of 29350E 203.
* The company expects its common stock to open for trading on a post-split basis on Nasdaq as of the commencement of trading on September 30, 2025.
* The reverse stock split is expected to reduce the number of shares of the company's common stock outstanding from approximately 231,780,434 shares to approximately 23,178,096 shares subject to some variability as a result of the fractional upward adjustments.
* RENB -24.68% after hours to $0.13.

* Source: Press Release [https://seekingalpha.com/pr/20243655-lunai-bioworks-inc-to-effect-10-1-reverse-stock-split]

MORE ON LUNAI BIOWORKS INC.

* Financial information for Lunai Bioworks Inc. [https://seekingalpha.com/symbol/RENB/income-statement]